nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCB1—peripheral nervous system neoplasm	0.26	1	CbGaD
Erythromycin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0577	0.0981	CbGbCtD
Erythromycin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0418	0.071	CbGbCtD
Erythromycin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0382	0.065	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0382	0.065	CbGbCtD
Erythromycin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0364	0.0619	CbGbCtD
Erythromycin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0355	0.0604	CbGbCtD
Erythromycin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0326	0.0553	CbGbCtD
Erythromycin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0287	0.0488	CbGbCtD
Erythromycin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.023	0.039	CbGbCtD
Erythromycin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0222	0.0377	CbGbCtD
Erythromycin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0201	0.0341	CbGbCtD
Erythromycin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0201	0.0341	CbGbCtD
Erythromycin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0184	0.0312	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0176	0.0298	CbGbCtD
Erythromycin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0176	0.0298	CbGbCtD
Erythromycin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0156	0.0265	CbGbCtD
Erythromycin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0139	0.0237	CbGbCtD
Erythromycin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0132	0.0224	CbGbCtD
Erythromycin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0121	0.0205	CbGbCtD
Erythromycin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.012	0.0205	CbGbCtD
Erythromycin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0112	0.019	CbGbCtD
Erythromycin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0105	0.0178	CbGbCtD
Erythromycin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00898	0.0153	CbGbCtD
Erythromycin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00857	0.0146	CbGbCtD
Erythromycin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.008	0.0136	CbGbCtD
Erythromycin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00786	0.0134	CbGbCtD
Erythromycin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00536	0.00911	CbGbCtD
Erythromycin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00514	0.00873	CbGbCtD
Erythromycin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00471	0.008	CbGbCtD
Erythromycin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00321	0.00546	CbGbCtD
Erythromycin—Roxithromycin—ABCB1—peripheral nervous system neoplasm	0.00062	0.283	CrCbGaD
Erythromycin—Azithromycin—ABCB1—peripheral nervous system neoplasm	0.00062	0.283	CrCbGaD
Erythromycin—Troleandomycin—ABCB1—peripheral nervous system neoplasm	0.000476	0.218	CrCbGaD
Erythromycin—Clarithromycin—ABCB1—peripheral nervous system neoplasm	0.00047	0.215	CrCbGaD
Erythromycin—Redness—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.0027	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.000395	0.00269	CcSEcCtD
Erythromycin—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000391	0.00266	CcSEcCtD
Erythromycin—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000391	0.00266	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000391	0.00266	CcSEcCtD
Erythromycin—Irritability—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00265	CcSEcCtD
Erythromycin—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000386	0.00263	CcSEcCtD
Erythromycin—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.00262	CcSEcCtD
Erythromycin—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00259	CcSEcCtD
Erythromycin—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00259	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00249	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00246	CcSEcCtD
Erythromycin—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00244	CcSEcCtD
Erythromycin—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00236	CcSEcCtD
Erythromycin—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000339	0.0023	CcSEcCtD
Erythromycin—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000339	0.0023	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.000337	0.00229	CcSEcCtD
Erythromycin—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000337	0.00229	CcSEcCtD
Erythromycin—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000337	0.00229	CcSEcCtD
Erythromycin—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00226	CcSEcCtD
Erythromycin—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00225	CcSEcCtD
Erythromycin—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00225	CcSEcCtD
Erythromycin—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.00225	CcSEcCtD
Erythromycin—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000327	0.00223	CcSEcCtD
Erythromycin—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000326	0.00222	CcSEcCtD
Erythromycin—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000325	0.00221	CcSEcCtD
Erythromycin—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000325	0.00221	CcSEcCtD
Erythromycin—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000323	0.0022	CcSEcCtD
Erythromycin—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00218	CcSEcCtD
Erythromycin—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00218	CcSEcCtD
Erythromycin—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00032	0.00218	CcSEcCtD
Erythromycin—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000318	0.00216	CcSEcCtD
Erythromycin—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00214	CcSEcCtD
Erythromycin—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00213	CcSEcCtD
Erythromycin—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00213	CcSEcCtD
Erythromycin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000314	0.00213	CcSEcCtD
Erythromycin—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.00212	CcSEcCtD
Erythromycin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00212	CcSEcCtD
Erythromycin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00212	CcSEcCtD
Erythromycin—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.00211	CcSEcCtD
Erythromycin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000307	0.00209	CcSEcCtD
Erythromycin—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000299	0.00203	CcSEcCtD
Erythromycin—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000297	0.00202	CcSEcCtD
Erythromycin—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000297	0.00202	CcSEcCtD
Erythromycin—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00202	CcSEcCtD
Erythromycin—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000293	0.00199	CcSEcCtD
Erythromycin—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00197	CcSEcCtD
Erythromycin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00197	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000286	0.00195	CcSEcCtD
Erythromycin—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000281	0.00191	CcSEcCtD
Erythromycin—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00188	CcSEcCtD
Erythromycin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000273	0.00186	CcSEcCtD
Erythromycin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000271	0.00184	CcSEcCtD
Erythromycin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000271	0.00184	CcSEcCtD
Erythromycin—Pain—Topotecan—peripheral nervous system neoplasm	0.000268	0.00182	CcSEcCtD
Erythromycin—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00182	CcSEcCtD
Erythromycin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000267	0.00182	CcSEcCtD
Erythromycin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000266	0.00181	CcSEcCtD
Erythromycin—Pain—Tretinoin—peripheral nervous system neoplasm	0.000266	0.00181	CcSEcCtD
Erythromycin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000264	0.00179	CcSEcCtD
Erythromycin—Pain—Melphalan—peripheral nervous system neoplasm	0.000263	0.00179	CcSEcCtD
Erythromycin—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.00178	CcSEcCtD
Erythromycin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000259	0.00176	CcSEcCtD
Erythromycin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000257	0.00174	CcSEcCtD
Erythromycin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000256	0.00174	CcSEcCtD
Erythromycin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000256	0.00174	CcSEcCtD
Erythromycin—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00174	CcSEcCtD
Erythromycin—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.00174	CcSEcCtD
Erythromycin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00173	CcSEcCtD
Erythromycin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00173	CcSEcCtD
Erythromycin—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00172	CcSEcCtD
Erythromycin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.0017	CcSEcCtD
Erythromycin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00025	0.0017	CcSEcCtD
Erythromycin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000249	0.0017	CcSEcCtD
Erythromycin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000248	0.00169	CcSEcCtD
Erythromycin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.00168	CcSEcCtD
Erythromycin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000247	0.00168	CcSEcCtD
Erythromycin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000246	0.00167	CcSEcCtD
Erythromycin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00167	CcSEcCtD
Erythromycin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000246	0.00167	CcSEcCtD
Erythromycin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000246	0.00167	CcSEcCtD
Erythromycin—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000245	0.00167	CcSEcCtD
Erythromycin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000244	0.00166	CcSEcCtD
Erythromycin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00165	CcSEcCtD
Erythromycin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.00165	CcSEcCtD
Erythromycin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000241	0.00164	CcSEcCtD
Erythromycin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00163	CcSEcCtD
Erythromycin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00162	CcSEcCtD
Erythromycin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.0016	CcSEcCtD
Erythromycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000231	0.00157	CcSEcCtD
Erythromycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000229	0.00156	CcSEcCtD
Erythromycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000229	0.00156	CcSEcCtD
Erythromycin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000227	0.00155	CcSEcCtD
Erythromycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000226	0.00154	CcSEcCtD
Erythromycin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00153	CcSEcCtD
Erythromycin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00151	CcSEcCtD
Erythromycin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000222	0.00151	CcSEcCtD
Erythromycin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000221	0.0015	CcSEcCtD
Erythromycin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000221	0.0015	CcSEcCtD
Erythromycin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00022	0.0015	CcSEcCtD
Erythromycin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.0015	CcSEcCtD
Erythromycin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.00148	CcSEcCtD
Erythromycin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000217	0.00148	CcSEcCtD
Erythromycin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000217	0.00147	CcSEcCtD
Erythromycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000215	0.00146	CcSEcCtD
Erythromycin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00145	CcSEcCtD
Erythromycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000213	0.00145	CcSEcCtD
Erythromycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000213	0.00145	CcSEcCtD
Erythromycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00021	0.00143	CcSEcCtD
Erythromycin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00143	CcSEcCtD
Erythromycin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00141	CcSEcCtD
Erythromycin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000207	0.00141	CcSEcCtD
Erythromycin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000207	0.00141	CcSEcCtD
Erythromycin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000206	0.0014	CcSEcCtD
Erythromycin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000206	0.0014	CcSEcCtD
Erythromycin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00139	CcSEcCtD
Erythromycin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000203	0.00138	CcSEcCtD
Erythromycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00137	CcSEcCtD
Erythromycin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000201	0.00137	CcSEcCtD
Erythromycin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00137	CcSEcCtD
Erythromycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000199	0.00136	CcSEcCtD
Erythromycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00135	CcSEcCtD
Erythromycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00135	CcSEcCtD
Erythromycin—Rash—Topotecan—peripheral nervous system neoplasm	0.000198	0.00135	CcSEcCtD
Erythromycin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000198	0.00134	CcSEcCtD
Erythromycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000196	0.00133	CcSEcCtD
Erythromycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000196	0.00133	CcSEcCtD
Erythromycin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000195	0.00133	CcSEcCtD
Erythromycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000195	0.00133	CcSEcCtD
Erythromycin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00132	CcSEcCtD
Erythromycin—Pain—Vincristine—peripheral nervous system neoplasm	0.000194	0.00132	CcSEcCtD
Erythromycin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00132	CcSEcCtD
Erythromycin—Rash—Melphalan—peripheral nervous system neoplasm	0.000194	0.00132	CcSEcCtD
Erythromycin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00131	CcSEcCtD
Erythromycin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000192	0.00131	CcSEcCtD
Erythromycin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000192	0.0013	CcSEcCtD
Erythromycin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00019	0.00129	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00129	CcSEcCtD
Erythromycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.00127	CcSEcCtD
Erythromycin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00127	CcSEcCtD
Erythromycin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.00127	CcSEcCtD
Erythromycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000186	0.00127	CcSEcCtD
Erythromycin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.00126	CcSEcCtD
Erythromycin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000186	0.00126	CcSEcCtD
Erythromycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000185	0.00126	CcSEcCtD
Erythromycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.00126	CcSEcCtD
Erythromycin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000184	0.00125	CcSEcCtD
Erythromycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000182	0.00124	CcSEcCtD
Erythromycin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00018	0.00122	CcSEcCtD
Erythromycin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00122	CcSEcCtD
Erythromycin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00121	CcSEcCtD
Erythromycin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000176	0.00119	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00119	CcSEcCtD
Erythromycin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000175	0.00119	CcSEcCtD
Erythromycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.00118	CcSEcCtD
Erythromycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.00118	CcSEcCtD
Erythromycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00117	CcSEcCtD
Erythromycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000167	0.00114	CcSEcCtD
Erythromycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00114	CcSEcCtD
Erythromycin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00113	CcSEcCtD
Erythromycin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00112	CcSEcCtD
Erythromycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.0011	CcSEcCtD
Erythromycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.0011	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00109	CcSEcCtD
Erythromycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00016	0.00109	CcSEcCtD
Erythromycin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00016	0.00109	CcSEcCtD
Erythromycin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00107	CcSEcCtD
Erythromycin—Pain—Etoposide—peripheral nervous system neoplasm	0.000157	0.00107	CcSEcCtD
Erythromycin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.00106	CcSEcCtD
Erythromycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000156	0.00106	CcSEcCtD
Erythromycin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000152	0.00103	CcSEcCtD
Erythromycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.00103	CcSEcCtD
Erythromycin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.00102	CcSEcCtD
Erythromycin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00015	0.00102	CcSEcCtD
Erythromycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00102	CcSEcCtD
Erythromycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00101	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00101	CcSEcCtD
Erythromycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000148	0.00101	CcSEcCtD
Erythromycin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000146	0.000995	CcSEcCtD
Erythromycin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000993	CcSEcCtD
Erythromycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000146	0.00099	CcSEcCtD
Erythromycin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000988	CcSEcCtD
Erythromycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000145	0.000983	CcSEcCtD
Erythromycin—Rash—Vincristine—peripheral nervous system neoplasm	0.000143	0.000975	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000142	0.0576	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.000141	0.0569	CbGpPWpGaD
Erythromycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000953	CcSEcCtD
Erythromycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000935	CcSEcCtD
Erythromycin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000934	CcSEcCtD
Erythromycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000136	0.000923	CcSEcCtD
Erythromycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000921	CcSEcCtD
Erythromycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000135	0.000918	CcSEcCtD
Erythromycin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000914	CcSEcCtD
Erythromycin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00013	0.000886	CcSEcCtD
Erythromycin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000883	CcSEcCtD
Erythromycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000869	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000127	0.0515	CbGpPWpGaD
Erythromycin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000864	CcSEcCtD
Erythromycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000862	CcSEcCtD
Erythromycin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00086	CcSEcCtD
Erythromycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000126	0.000857	CcSEcCtD
Erythromycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000852	CcSEcCtD
Erythromycin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000842	CcSEcCtD
Erythromycin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000122	0.000828	CcSEcCtD
Erythromycin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000817	CcSEcCtD
Erythromycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000812	CcSEcCtD
Erythromycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000117	0.000796	CcSEcCtD
Erythromycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000796	CcSEcCtD
Erythromycin—Rash—Etoposide—peripheral nervous system neoplasm	0.000116	0.00079	CcSEcCtD
Erythromycin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000779	CcSEcCtD
Erythromycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000773	CcSEcCtD
Erythromycin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00076	CcSEcCtD
Erythromycin—ABCC1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000112	0.0452	CbGpPWpGaD
Erythromycin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000745	CcSEcCtD
Erythromycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000109	0.000744	CcSEcCtD
Erythromycin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000732	CcSEcCtD
Erythromycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000723	CcSEcCtD
Erythromycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000715	CcSEcCtD
Erythromycin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000708	CcSEcCtD
Erythromycin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000703	CcSEcCtD
Erythromycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000702	CcSEcCtD
Erythromycin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00069	CcSEcCtD
Erythromycin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000678	CcSEcCtD
Erythromycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000669	CcSEcCtD
Erythromycin—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000669	CcSEcCtD
Erythromycin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.63e-05	0.000655	CcSEcCtD
Erythromycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.00065	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	9.43e-05	0.0381	CbGpPWpGaD
Erythromycin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000619	CcSEcCtD
Erythromycin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.00061	CcSEcCtD
Erythromycin—Pain—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.0006	CcSEcCtD
Erythromycin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000578	CcSEcCtD
Erythromycin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000574	CcSEcCtD
Erythromycin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000565	CcSEcCtD
Erythromycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000558	CcSEcCtD
Erythromycin—Pain—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000555	CcSEcCtD
Erythromycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000555	CcSEcCtD
Erythromycin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000535	CcSEcCtD
Erythromycin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000531	CcSEcCtD
Erythromycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000517	CcSEcCtD
Erythromycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000516	CcSEcCtD
Erythromycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000513	CcSEcCtD
Erythromycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000497	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	7.18e-05	0.029	CbGpPWpGaD
Erythromycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.00048	CcSEcCtD
Erythromycin—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	7.04e-05	0.0285	CbGpPWpGaD
Erythromycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000479	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.89e-05	0.0278	CbGpPWpGaD
Erythromycin—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000464	CcSEcCtD
Erythromycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.00046	CcSEcCtD
Erythromycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000446	CcSEcCtD
Erythromycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000444	CcSEcCtD
Erythromycin—Rash—Epirubicin—peripheral nervous system neoplasm	6.51e-05	0.000443	CcSEcCtD
Erythromycin—MLNR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	6.4e-05	0.0259	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	6.32e-05	0.0255	CbGpPWpGaD
Erythromycin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.00043	CcSEcCtD
Erythromycin—Nausea—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000417	CcSEcCtD
Erythromycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000413	CcSEcCtD
Erythromycin—Rash—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00041	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	5.72e-05	0.0231	CbGpPWpGaD
Erythromycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000386	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	4.24e-05	0.0171	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	4.06e-05	0.0164	CbGpPWpGaD
Erythromycin—ABCC1—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	3.95e-05	0.016	CbGpPWpGaD
Erythromycin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	3.86e-05	0.0156	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.69e-05	0.0149	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.53e-05	0.0143	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.48e-05	0.0141	CbGpPWpGaD
Erythromycin—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	3.28e-05	0.0132	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.23e-05	0.013	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.08e-05	0.0124	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.82e-05	0.0114	CbGpPWpGaD
Erythromycin—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.8e-05	0.0113	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.79e-05	0.0113	CbGpPWpGaD
Erythromycin—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.74e-05	0.0111	CbGpPWpGaD
Erythromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.0108	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.58e-05	0.0104	CbGpPWpGaD
Erythromycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	2.47e-05	0.01	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	2.33e-05	0.0094	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.18e-05	0.0088	CbGpPWpGaD
Erythromycin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	2.11e-05	0.00854	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.09e-05	0.00846	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.09e-05	0.00844	CbGpPWpGaD
Erythromycin—SLC22A7—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	2.06e-05	0.00831	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.82e-05	0.00737	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.73e-05	0.007	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.66e-05	0.0067	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.65e-05	0.00667	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.59e-05	0.00645	CbGpPWpGaD
Erythromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.57e-05	0.00636	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.56e-05	0.0063	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.53e-05	0.0062	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.53e-05	0.00619	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.52e-05	0.00616	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.47e-05	0.00595	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	1.47e-05	0.00593	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.45e-05	0.00586	CbGpPWpGaD
Erythromycin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.27e-05	0.00515	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	1.23e-05	0.00498	CbGpPWpGaD
Erythromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.21e-05	0.00491	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.00463	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.14e-05	0.00462	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.14e-05	0.00462	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.1e-05	0.00444	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.03e-05	0.00416	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.00407	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.89e-06	0.004	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.78e-06	0.00396	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.32e-06	0.00377	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.96e-06	0.00362	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.55e-06	0.00346	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.79e-06	0.00315	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.71e-06	0.00312	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.94e-06	0.00281	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.63e-06	0.00268	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.48e-06	0.00262	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.41e-06	0.00259	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.27e-06	0.00253	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.15e-06	0.00249	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.05e-06	0.00245	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.05e-06	0.00245	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6.03e-06	0.00244	CbGpPWpGaD
Erythromycin—ABCC1—Disease—GNS—peripheral nervous system neoplasm	5.99e-06	0.00242	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.95e-06	0.0024	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.92e-06	0.00239	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.83e-06	0.00236	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.81e-06	0.00235	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.77e-06	0.00233	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	5.58e-06	0.00225	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.5e-06	0.00222	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	5.35e-06	0.00216	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	5.26e-06	0.00213	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.23e-06	0.00212	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	5.15e-06	0.00208	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	5.1e-06	0.00206	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.03e-06	0.00204	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	5.02e-06	0.00203	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	4.89e-06	0.00198	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.89e-06	0.00198	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	4.81e-06	0.00195	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.7e-06	0.0019	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.7e-06	0.0019	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.68e-06	0.00189	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	4.63e-06	0.00187	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.59e-06	0.00186	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.48e-06	0.00181	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.43e-06	0.00179	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	4.38e-06	0.00177	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.38e-06	0.00177	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.3e-06	0.00174	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.26e-06	0.00172	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.21e-06	0.0017	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	4.2e-06	0.0017	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	4.19e-06	0.00169	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.13e-06	0.00167	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	4.04e-06	0.00163	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.91e-06	0.00158	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.9e-06	0.00158	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	3.84e-06	0.00155	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	3.63e-06	0.00147	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.57e-06	0.00145	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.38e-06	0.00137	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.33e-06	0.00135	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.3e-06	0.00134	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	3.24e-06	0.00131	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.19e-06	0.00129	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	3.16e-06	0.00128	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	3.1e-06	0.00125	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	3.04e-06	0.00123	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	3.03e-06	0.00123	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.01e-06	0.00122	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.99e-06	0.00121	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	2.93e-06	0.00118	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.92e-06	0.00118	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.85e-06	0.00115	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.77e-06	0.00112	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.73e-06	0.00111	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.72e-06	0.0011	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	2.68e-06	0.00109	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	2.65e-06	0.00107	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.64e-06	0.00107	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.62e-06	0.00106	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	2.57e-06	0.00104	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.51e-06	0.00102	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.49e-06	0.00101	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.45e-06	0.000991	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	2.42e-06	0.000977	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.39e-06	0.000965	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.31e-06	0.000934	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.29e-06	0.000926	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	2.24e-06	0.000906	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.2e-06	0.000891	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.19e-06	0.000886	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.19e-06	0.000886	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.15e-06	0.000869	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.14e-06	0.000864	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	2.11e-06	0.000852	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.03e-06	0.000823	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2e-06	0.00081	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.97e-06	0.000797	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.96e-06	0.000794	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-06	0.000793	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.93e-06	0.000782	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.92e-06	0.000775	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.91e-06	0.000771	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.83e-06	0.000739	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.76e-06	0.000711	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.72e-06	0.000695	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.69e-06	0.000682	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-06	0.00067	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1.64e-06	0.000662	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.62e-06	0.000655	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.61e-06	0.000652	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-06	0.000639	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.56e-06	0.00063	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.55e-06	0.000625	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.52e-06	0.000616	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.47e-06	0.000595	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.45e-06	0.000585	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-06	0.00057	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.36e-06	0.000551	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.36e-06	0.000549	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	1.29e-06	0.000523	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-06	0.000514	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-06	0.000505	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-06	0.000503	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.22e-06	0.000494	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-06	0.000493	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.17e-06	0.000471	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.15e-06	0.000467	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.15e-06	0.000465	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	9.84e-07	0.000398	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	9.76e-07	0.000395	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.38e-07	0.000379	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.31e-07	0.000376	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	9.17e-07	0.000371	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	9.16e-07	0.000371	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.91e-07	0.00036	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	7.53e-07	0.000304	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	7.49e-07	0.000303	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.35e-07	0.000297	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	7.2e-07	0.000291	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.18e-07	0.00029	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.08e-07	0.000286	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	6.35e-07	0.000257	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	5.91e-07	0.000239	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.78e-07	0.000234	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.67e-07	0.000229	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	5.32e-07	0.000215	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	4.64e-07	0.000188	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.43e-07	0.000139	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.36e-07	0.000136	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.53e-07	0.000102	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.02e-07	8.17e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-07	6.31e-05	CbGpPWpGaD
